Important considerations in calculating and reporting of sample size in randomized controlled trials

Area of Science:

• Biostatistics
• Clinical Trials
• Research Methodology

Background:

• Sample size calculation is a critical component in the design of randomized controlled trials (RCTs).
• Inadequate sample size can lead to underpowered studies, affecting the reliability of results.
• Proper sample size determination is essential for ethical and efficient research conduct.

Purpose of the Study:

• To emphasize the significance of calculating and reporting sample sizes in randomized controlled trials.
• To highlight the CONSORT guidelines and other standards for sample size reporting.
• To underscore the importance of statistical consultation in sample size determination.

Main Methods:

• Review of relevant scientific literature and established guidelines.
• Discussion of critical aspects of sample size calculation and reporting in RCTs.
• Analysis of ethical and financial implications of sample size decisions.

Main Results:

• Sample size calculations are fundamental to robust randomized controlled trial design.
• Reporting and justification of sample size are mandated by CONSORT and other key guidelines.
• Sample size calculations are susceptible to bias, necessitating careful consideration.

Conclusions:

• Sample size calculation and reporting are indispensable for all published randomized controlled trials.
• Adherence to CONSORT guidelines ensures transparency and reproducibility.
• Engaging biostatisticians early in the design phase is recommended for accurate sample size determination and to mitigate bias.